| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/22/2001 | WO2001019846A1 Transgenically produced fusion proteins |
| 03/22/2001 | WO2001019845A1 Cacna1g polynucleotide, polypeptide and methods of use therefor |
| 03/22/2001 | WO2001019844A1 Altered nucleotide sequence in cd40 ligand promotor |
| 03/22/2001 | WO2001019410A2 Human flash and uses thereof |
| 03/22/2001 | WO2001019408A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019395A1 Acellular immunogenic compositions and acellular vaccine compositions against bacillus anthracis |
| 03/22/2001 | WO2001019393A1 Delivering to eucaryotic cells bacterial proteins that are secreted via type iii secretion systems |
| 03/22/2001 | WO2001019389A1 Remedies for rheumatoid arthritis and fused protein |
| 03/22/2001 | WO2001019380A2 Oncolytic virus |
| 03/22/2001 | WO2001019186A1 Composition and method for treating wounds |
| 03/22/2001 | WO2001019183A2 Development of an effective gene transfer technique for introducing foreign dna into sperm cells |
| 03/22/2001 | WO2001009332A3 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 03/22/2001 | WO2001001749A3 FVIIa ANTAGONISTS |
| 03/22/2001 | WO2000071693A3 Method for selecting improved vectors |
| 03/22/2001 | WO2000071567A3 Fibroblast growth factor 13 |
| 03/22/2001 | WO2000066623A3 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
| 03/22/2001 | WO2000065038A3 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
| 03/22/2001 | WO2000063242A8 Chimeric lyssavirus nucleic acids and polypeptides |
| 03/22/2001 | WO2000060066A8 Protein-protein from s. cerevisiae and methods of using same |
| 03/22/2001 | WO2000058453A3 Plants transformed with thioredoxin |
| 03/22/2001 | WO2000055629A3 Methods of diagnosing and treating breast cancer |
| 03/22/2001 | WO2000055318A3 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 03/22/2001 | WO2000046245A8 Human antibiotic proteins |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | WO2000030672A9 Collagen based biomaterials and methods of preparation and use |
| 03/22/2001 | WO2000028056A9 HYPERSENSITIVE RESPONSE ELICITOR FROM $i(AGROBACTERIUM VITIS) |
| 03/22/2001 | WO2000020591A9 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 03/22/2001 | WO2000018421A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 03/22/2001 | WO2000013019A9 Receptor for underivatized, aqueous soluble beta-(1,3)-glucan |
| 03/22/2001 | WO2000012302A9 Bioriented polyethylene film with a high water vapor transmission rate |
| 03/22/2001 | WO2000000601A9 Production of low-temperature, salt-and drought-tolerant transgenic cereal plants |
| 03/22/2001 | WO1999061656A3 Agent and method for modulation of cell migration |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | WO1999050414A9 Blk genes, gene products and uses thereof in apoptosis |
| 03/22/2001 | DE19944626A1 Producing active bone morphogenic protein dimers, useful for inducing growth of bone and cartilage comprises expressing soluble fusion protein monomer followed by refolding and dimerization |
| 03/22/2001 | DE19944402A1 Entwicklung einer effektiven Gentransfertechnik für das Einschleusen von Fremd-DNS in Spermienzellen Development of an effective gene transfer technology for the smuggling of foreign DNA in sperm cells |
| 03/22/2001 | DE10031122A1 Composition for the treatment of malignant diseases comprises agents that reduce concentration of YB-1 protein or inhibit its translocation in tumor cells |
| 03/22/2001 | CA2749232A1 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse |
| 03/22/2001 | CA2749181A1 System and method for processing tokenless biometric electronic transmissions using an electronic rule module clearinghouse |
| 03/22/2001 | CA2388419A1 Cacna1g polynucleotide, polypeptide and methods of use therefor |
| 03/22/2001 | CA2388072A1 Transcriptionally silenced plant genes |
| 03/22/2001 | CA2385308A1 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | CA2385234A1 Nrage nucleic acids and polypeptides and uses thereof |
| 03/22/2001 | CA2384987A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | CA2384967A1 Lepidopteran-active bacillus thuringiensis .delta.-endotoxin compositions and methods of use |
| 03/22/2001 | CA2384920A1 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 03/22/2001 | CA2384916A1 Plants having altered amino acid contents and method for the production thereof |
| 03/22/2001 | CA2384762A1 Apo-2 receptor antibodies |
| 03/22/2001 | CA2384749A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | CA2384733A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2384294A1 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | CA2384271A1 Stabilized soluble glycoprotein trimers |
| 03/22/2001 | CA2383360A1 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | CA2383292A1 Basb128 polypeptide and polynucleotide from moxarella catarrhalis |
| 03/22/2001 | CA2383177A1 Human g-protein coupled receptor |
| 03/22/2001 | CA2383081A1 Polypeptides from moraxella (branhamella) catarrhalis |
| 03/22/2001 | CA2382725A1 Transgenically produced fusion proteins |
| 03/22/2001 | CA2382544A1 Methods of peptide preparation |
| 03/22/2001 | CA2382067A1 Recombinant microorganisms |
| 03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2344155A1 Methods for selecting prostate cancer treatments and treating prostate cancer |
| 03/21/2001 | EP1085323A2 NADE binding proteins |
| 03/21/2001 | EP1085092A1 Phosphodiesterase enzymes |
| 03/21/2001 | EP1085091A1 Nucleotide sequences coding for thrE-gene and process for the fermentative preparation of L-threonine using coryneform bacteria |
| 03/21/2001 | EP1085090A1 IgA NEPHROPATHY-ASSOCIATED DNA |
| 03/21/2001 | EP1085024A1 Peptides having nuclear transport activity |
| 03/21/2001 | EP1084409A1 Method and device for electrochemical immunoassay of multiple analytes |
| 03/21/2001 | EP1084274A1 Acrp30r2, a homolog of acrp30 (30 kd adipocyte complement-related protein) |
| 03/21/2001 | EP1084262A1 Promoter and constructions for expression of recombinant proteins in filamentous fungi |
| 03/21/2001 | EP1084261A1 Recombinant venezuelan equine encephalitis virus vaccine |
| 03/21/2001 | EP1084254A1 Transgenic plants presenting a modified inulin producing profile |
| 03/21/2001 | EP1084253A1 Hiv virus mimotopes |
| 03/21/2001 | EP1084252A1 Nucleic acid vaccines for prevention of flavivirus infection |
| 03/21/2001 | EP1084251A2 Attenuated pestiviruses |
| 03/21/2001 | EP1084249A2 Transgenic plant cells expressing a recombinant plant e2f peptide |
| 03/21/2001 | EP1084248A2 Novel insulin analogs with enhanced zinc binding |
| 03/21/2001 | EP1084247A1 Disulfide core polypeptides |
| 03/21/2001 | EP1084245A1 Human receptor tyrosine kinase |
| 03/21/2001 | EP1084244A1 Tnfr-like protein with death domain |
| 03/21/2001 | EP1084243A2 Protein for regulating apoptosis |
| 03/21/2001 | EP1084242A2 Phagocytic assay method |
| 03/21/2001 | EP1084241A1 G-protein coupled receptor, named 2871 receptor |
| 03/21/2001 | EP1084239A1 Polymorphic markers of prostate carcinoma tumor antigen-1 (pcta-1) |
| 03/21/2001 | EP1084238A1 Dna encoding orphan receptors |
| 03/21/2001 | EP1084236A1 Novel adenoviral vectors for gene therapy |
| 03/21/2001 | EP1084231A1 Transformed cell lines which express heterologous g-protein-coupled receptors |
| 03/21/2001 | EP1084227A1 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 03/21/2001 | EP1084146A2 Hybrid protein for inhibiting the degranulation of mastocytes and the use thereof |
| 03/21/2001 | EP1084144A2 Improvements in or relating to uptake of substances by cells |
| 03/21/2001 | EP1084143A1 Purification process for production of mannan-binding lectin and an mbl medicinal product |
| 03/21/2001 | EP1084142A1 Gpr35a receptor |
| 03/21/2001 | EP1084136A1 Separation of protein monomers from aggregates by use of ion-exchange chromatography |
| 03/21/2001 | EP1084135A1 The human kidney specific gene kk86 |
| 03/21/2001 | EP1084133A1 Redox reversible bipyridyl osmium complex conjugates |
| 03/21/2001 | EP1084132A1 Redox reversible imidazole-osmium complex conjugates |
| 03/21/2001 | EP1083934A2 Gene therapy method |
| 03/21/2001 | EP1083927A1 HUMAN MINOR VAULT PROTEIN p193 |